0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Vaccine Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-12116
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Veterinary Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Veterinary Vaccine Market Insights and Forecast to 2028

Code: QYRE-Auto-12116
Report
January 2022
128 Pages
QYResearch
Region: Global, Europe, North America, China
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Vaccine Market Outlook - 2028

Due to the COVID-19 pandemic, the global Veterinary Vaccine market size is estimated to be worth US$ 8853.6 million in 2022 and is forecast to a readjusted size of US$ 12630 million by 2028 with a CAGR of 6.1% during the review period.

Veterinary Vaccine Market

Fully considering the economic change by this health crisis, Live Attenuated Vaccines accounting for % of the Veterinary Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Livestock segment is altered to an % CAGR throughout this forecast period.

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

Veterinary Vaccine Market Analysis and Insights

Global Veterinary Vaccine key players include Merck, Boehringer Ingelheim, Zoetis, Ceva, Elanco, etc. Global top five manufacturers hold a share about 75%. North America and Asia Pacific is the largest market, both with a share about 30%, followed by Europe, with a share about 25 percent. In terms of product, Live Attenuated Vaccines is the largest segment, with a share about 60%. And in terms of application, the largest application is Dog & Cat, followed by Livestock, Swine, Chicken, etc.

Veterinary Vaccine Market Scope and Segment

Veterinary Vaccine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Veterinary Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Veterinary Vaccine Market Segment By Type

  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Others

Veterinary Vaccine Market Segment By Application

  • Livestock
  • Swine
  • Chicken
  • Dog & Cat
  • Others

By Company

  • Merck
  • Zoetis
  • Boehringer Ingelheim
  • Ceva
  • CAHIC
  • HVRI
  • Ringpu Biology
  • Yebio
  • DHN
  • WINSUN
  • Elanco
  • Virbac
  • Jinyu Bio-Technology
  • ChengDu Tecbond
  • CAVAC
  • Kyoto Biken Laboratories
  • FATRO
  • Vaksindo
  • Bio-Labs
  • Avimex Animal Health
  • MEVAC
  • Biovac
  • Atafen
  • Dyntec
  • BioTestLab
  • RVSRI
  • Medion

By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Greece
  • Ukraine
  • Moldova
  • Albania
  • Serbia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • U.A.E
  • Egypt
  • South Africa
  • Israel
  • Kuwait
  • Iran
1 Study Coverage
1.1 Veterinary Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Veterinary Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Others
1.3 Market by Application
1.3.1 Global Veterinary Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Livestock
1.3.3 Swine
1.3.4 Chicken
1.3.5 Dog & Cat
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Veterinary Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Veterinary Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Veterinary Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Veterinary Vaccine Sales by Region
2.4.1 Global Veterinary Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Veterinary Vaccine by Region (2023-2028)
2.5 Global Veterinary Vaccine Revenue by Region
2.5.1 Global Veterinary Vaccine Revenue by Region (2017-2022)
2.5.2 Global Veterinary Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Veterinary Vaccine Sales by Manufacturers
3.1.1 Global Top Veterinary Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Veterinary Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Veterinary Vaccine in 2021
3.2 Global Veterinary Vaccine Revenue by Manufacturers
3.2.1 Global Veterinary Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Veterinary Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Veterinary Vaccine Revenue in 2021
3.3 Global Veterinary Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Veterinary Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Veterinary Vaccine Sales by Type
4.1.1 Global Veterinary Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Veterinary Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Veterinary Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Veterinary Vaccine Revenue by Type
4.2.1 Global Veterinary Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Veterinary Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Veterinary Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Veterinary Vaccine Price by Type
4.3.1 Global Veterinary Vaccine Price by Type (2017-2022)
4.3.2 Global Veterinary Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Veterinary Vaccine Sales by Application
5.1.1 Global Veterinary Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Veterinary Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Veterinary Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Veterinary Vaccine Revenue by Application
5.2.1 Global Veterinary Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Veterinary Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Veterinary Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Veterinary Vaccine Price by Application
5.3.1 Global Veterinary Vaccine Price by Application (2017-2022)
5.3.2 Global Veterinary Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Veterinary Vaccine Market Size by Type
6.1.1 North America Veterinary Vaccine Sales by Type (2017-2028)
6.1.2 North America Veterinary Vaccine Revenue by Type (2017-2028)
6.2 North America Veterinary Vaccine Market Size by Application
6.2.1 North America Veterinary Vaccine Sales by Application (2017-2028)
6.2.2 North America Veterinary Vaccine Revenue by Application (2017-2028)
6.3 North America Veterinary Vaccine Market Size by Country
6.3.1 North America Veterinary Vaccine Sales by Country (2017-2028)
6.3.2 North America Veterinary Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Veterinary Vaccine Market Size by Type
7.1.1 Europe Veterinary Vaccine Sales by Type (2017-2028)
7.1.2 Europe Veterinary Vaccine Revenue by Type (2017-2028)
7.2 Europe Veterinary Vaccine Market Size by Application
7.2.1 Europe Veterinary Vaccine Sales by Application (2017-2028)
7.2.2 Europe Veterinary Vaccine Revenue by Application (2017-2028)
7.3 Europe Veterinary Vaccine Market Size by Country
7.3.1 Europe Veterinary Vaccine Sales by Country (2017-2028)
7.3.2 Europe Veterinary Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
7.3.8 Greece
8 Asia Pacific
8.1 Asia Pacific Veterinary Vaccine Market Size by Type
8.1.1 Asia Pacific Veterinary Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Veterinary Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Veterinary Vaccine Market Size by Application
8.2.1 Asia Pacific Veterinary Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Veterinary Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Veterinary Vaccine Market Size by Region
8.3.1 Asia Pacific Veterinary Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Veterinary Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Veterinary Vaccine Market Size by Type
9.1.1 Latin America Veterinary Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Veterinary Vaccine Revenue by Type (2017-2028)
9.2 Latin America Veterinary Vaccine Market Size by Application
9.2.1 Latin America Veterinary Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Veterinary Vaccine Revenue by Application (2017-2028)
9.3 Latin America Veterinary Vaccine Market Size by Country
9.3.1 Latin America Veterinary Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Veterinary Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Veterinary Vaccine Market Size by Type
10.1.1 Middle East and Africa Veterinary Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Veterinary Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Veterinary Vaccine Market Size by Application
10.2.1 Middle East and Africa Veterinary Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Veterinary Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Veterinary Vaccine Market Size by Country
10.3.1 Middle East and Africa Veterinary Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Veterinary Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.6 Egypt
10.3.7 South Africa
10.3.8 Israel
10.3.9 Kuwait
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Zoetis
11.2.1 Zoetis Corporation Information
11.2.2 Zoetis Overview
11.2.3 Zoetis Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Zoetis Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Zoetis Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boehringer Ingelheim Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Ceva
11.4.1 Ceva Corporation Information
11.4.2 Ceva Overview
11.4.3 Ceva Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ceva Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ceva Recent Developments
11.5 CAHIC
11.5.1 CAHIC Corporation Information
11.5.2 CAHIC Overview
11.5.3 CAHIC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CAHIC Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CAHIC Recent Developments
11.6 HVRI
11.6.1 HVRI Corporation Information
11.6.2 HVRI Overview
11.6.3 HVRI Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 HVRI Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 HVRI Recent Developments
11.7 Ringpu Biology
11.7.1 Ringpu Biology Corporation Information
11.7.2 Ringpu Biology Overview
11.7.3 Ringpu Biology Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ringpu Biology Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ringpu Biology Recent Developments
11.8 Yebio
11.8.1 Yebio Corporation Information
11.8.2 Yebio Overview
11.8.3 Yebio Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Yebio Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Yebio Recent Developments
11.9 DHN
11.9.1 DHN Corporation Information
11.9.2 DHN Overview
11.9.3 DHN Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 DHN Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 DHN Recent Developments
11.10 WINSUN
11.10.1 WINSUN Corporation Information
11.10.2 WINSUN Overview
11.10.3 WINSUN Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 WINSUN Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 WINSUN Recent Developments
11.11 Elanco
11.11.1 Elanco Corporation Information
11.11.2 Elanco Overview
11.11.3 Elanco Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Elanco Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Elanco Recent Developments
11.12 Virbac
11.12.1 Virbac Corporation Information
11.12.2 Virbac Overview
11.12.3 Virbac Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Virbac Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Virbac Recent Developments
11.13 Jinyu Bio-Technology
11.13.1 Jinyu Bio-Technology Corporation Information
11.13.2 Jinyu Bio-Technology Overview
11.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Jinyu Bio-Technology Recent Developments
11.14 ChengDu Tecbond
11.14.1 ChengDu Tecbond Corporation Information
11.14.2 ChengDu Tecbond Overview
11.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 ChengDu Tecbond Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 ChengDu Tecbond Recent Developments
11.15 CAVAC
11.15.1 CAVAC Corporation Information
11.15.2 CAVAC Overview
11.15.3 CAVAC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 CAVAC Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 CAVAC Recent Developments
11.16 Kyoto Biken Laboratories
11.16.1 Kyoto Biken Laboratories Corporation Information
11.16.2 Kyoto Biken Laboratories Overview
11.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Kyoto Biken Laboratories Recent Developments
11.17 FATRO
11.17.1 FATRO Corporation Information
11.17.2 FATRO Overview
11.17.3 FATRO Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 FATRO Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 FATRO Recent Developments
11.18 Vaksindo
11.18.1 Vaksindo Corporation Information
11.18.2 Vaksindo Overview
11.18.3 Vaksindo Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Vaksindo Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Vaksindo Recent Developments
11.19 Bio-Labs
11.19.1 Bio-Labs Corporation Information
11.19.2 Bio-Labs Overview
11.19.3 Bio-Labs Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Bio-Labs Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Bio-Labs Recent Developments
11.20 Avimex Animal Health
11.20.1 Avimex Animal Health Corporation Information
11.20.2 Avimex Animal Health Overview
11.20.3 Avimex Animal Health Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Avimex Animal Health Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Avimex Animal Health Recent Developments
11.21 MEVAC
11.21.1 MEVAC Corporation Information
11.21.2 MEVAC Overview
11.21.3 MEVAC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 MEVAC Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 MEVAC Recent Developments
11.22 Biovac
11.22.1 Biovac Corporation Information
11.22.2 Biovac Overview
11.22.3 Biovac Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Biovac Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Biovac Recent Developments
11.23 Atafen
11.23.1 Atafen Corporation Information
11.23.2 Atafen Overview
11.23.3 Atafen Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Atafen Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Atafen Recent Developments
11.24 Dyntec
11.24.1 Dyntec Corporation Information
11.24.2 Dyntec Overview
11.24.3 Dyntec Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Dyntec Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Dyntec Recent Developments
11.25 BioTestLab
11.25.1 BioTestLab Corporation Information
11.25.2 BioTestLab Overview
11.25.3 BioTestLab Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.25.4 BioTestLab Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 BioTestLab Recent Developments
11.26 RVSRI
11.26.1 RVSRI Corporation Information
11.26.2 RVSRI Overview
11.26.3 RVSRI Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.26.4 RVSRI Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.26.5 RVSRI Recent Developments
11.27 Medion
11.27.1 Medion Corporation Information
11.27.2 Medion Overview
11.27.3 Medion Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.27.4 Medion Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.27.5 Medion Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Veterinary Vaccine Industry Chain Analysis
12.2 Veterinary Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Veterinary Vaccine Production Mode & Process
12.4 Veterinary Vaccine Sales and Marketing
12.4.1 Veterinary Vaccine Sales Channels
12.4.2 Veterinary Vaccine Distributors
12.5 Veterinary Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Veterinary Vaccine Industry Trends
13.2 Veterinary Vaccine Market Drivers
13.3 Veterinary Vaccine Market Challenges
13.4 Veterinary Vaccine Market Restraints
14 Key Findings in The Global Veterinary Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Veterinary Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Live Attenuated Vaccines
    Table 3. Major Manufacturers of Inactivated Vaccines
    Table 4. Major Manufacturers of Others
    Table 5. Global Veterinary Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Veterinary Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Veterinary Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 8. Global Veterinary Vaccine Sales Market Share by Region (2017-2022)
    Table 9. Global Veterinary Vaccine Sales by Region (2023-2028) & (M Doses)
    Table 10. Global Veterinary Vaccine Sales Market Share by Region (2023-2028)
    Table 11. Global Veterinary Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Veterinary Vaccine Revenue Market Share by Region (2017-2022)
    Table 13. Global Veterinary Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Veterinary Vaccine Revenue Market Share by Region (2023-2028)
    Table 15. Global Veterinary Vaccine Sales by Manufacturers (2017-2022) & (M Doses)
    Table 16. Global Veterinary Vaccine Sales Share by Manufacturers (2017-2022)
    Table 17. Global Veterinary Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Veterinary Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 19. Veterinary Vaccine Price by Manufacturers (2017-2022) &(USD/Doses)
    Table 20. Global Veterinary Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Veterinary Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2021)
    Table 22. Veterinary Vaccine Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Veterinary Vaccine Product Offered
    Table 24. Date of Manufacturers Enter into Veterinary Vaccine Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Veterinary Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 27. Global Veterinary Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 28. Global Veterinary Vaccine Sales Share by Type (2017-2022)
    Table 29. Global Veterinary Vaccine Sales Share by Type (2023-2028)
    Table 30. Global Veterinary Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Veterinary Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Veterinary Vaccine Revenue Share by Type (2017-2022)
    Table 33. Global Veterinary Vaccine Revenue Share by Type (2023-2028)
    Table 34. Veterinary Vaccine Price by Type (2017-2022) & (USD/Doses)
    Table 35. Global Veterinary Vaccine Price Forecast by Type (2023-2028) & (USD/Doses)
    Table 36. Global Veterinary Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 37. Global Veterinary Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 38. Global Veterinary Vaccine Sales Share by Application (2017-2022)
    Table 39. Global Veterinary Vaccine Sales Share by Application (2023-2028)
    Table 40. Global Veterinary Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Veterinary Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Veterinary Vaccine Revenue Share by Application (2017-2022)
    Table 43. Global Veterinary Vaccine Revenue Share by Application (2023-2028)
    Table 44. Veterinary Vaccine Price by Application (2017-2022) & (USD/Doses)
    Table 45. Global Veterinary Vaccine Price Forecast by Application (2023-2028) & (USD/Doses)
    Table 46. North America Veterinary Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 47. North America Veterinary Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 48. North America Veterinary Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Veterinary Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Veterinary Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 51. North America Veterinary Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 52. North America Veterinary Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Veterinary Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Veterinary Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 55. North America Veterinary Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 56. North America Veterinary Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Veterinary Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Veterinary Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 59. Europe Veterinary Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 60. Europe Veterinary Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Veterinary Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Veterinary Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 63. Europe Veterinary Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 64. Europe Veterinary Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Veterinary Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Veterinary Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 67. Europe Veterinary Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 68. Europe Veterinary Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Veterinary Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Veterinary Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 71. Asia Pacific Veterinary Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 72. Asia Pacific Veterinary Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Veterinary Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Veterinary Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 75. Asia Pacific Veterinary Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 76. Asia Pacific Veterinary Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Veterinary Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Veterinary Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 79. Asia Pacific Veterinary Vaccine Sales by Region (2023-2028) & (M Doses)
    Table 80. Asia Pacific Veterinary Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Veterinary Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Veterinary Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 83. Latin America Veterinary Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 84. Latin America Veterinary Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Veterinary Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Veterinary Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 87. Latin America Veterinary Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 88. Latin America Veterinary Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Veterinary Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Veterinary Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 91. Latin America Veterinary Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 92. Latin America Veterinary Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Veterinary Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Veterinary Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 95. Middle East and Africa Veterinary Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 96. Middle East and Africa Veterinary Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Veterinary Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Veterinary Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 99. Middle East and Africa Veterinary Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 100. Middle East and Africa Veterinary Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Veterinary Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Veterinary Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 103. Middle East and Africa Veterinary Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 104. Middle East and Africa Veterinary Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Veterinary Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Merck Corporation Information
    Table 107. Merck Description and Major Businesses
    Table 108. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 109. Merck Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Merck Recent Developments
    Table 111. Zoetis Corporation Information
    Table 112. Zoetis Description and Major Businesses
    Table 113. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 114. Zoetis Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Zoetis Recent Developments
    Table 116. Boehringer Ingelheim Corporation Information
    Table 117. Boehringer Ingelheim Description and Major Businesses
    Table 118. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 119. Boehringer Ingelheim Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Boehringer Ingelheim Recent Developments
    Table 121. Ceva Corporation Information
    Table 122. Ceva Description and Major Businesses
    Table 123. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 124. Ceva Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Ceva Recent Developments
    Table 126. CAHIC Corporation Information
    Table 127. CAHIC Description and Major Businesses
    Table 128. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 129. CAHIC Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. CAHIC Recent Developments
    Table 131. HVRI Corporation Information
    Table 132. HVRI Description and Major Businesses
    Table 133. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 134. HVRI Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. HVRI Recent Developments
    Table 136. Ringpu Biology Corporation Information
    Table 137. Ringpu Biology Description and Major Businesses
    Table 138. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 139. Ringpu Biology Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Ringpu Biology Recent Developments
    Table 141. Yebio Corporation Information
    Table 142. Yebio Description and Major Businesses
    Table 143. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 144. Yebio Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Yebio Recent Developments
    Table 146. DHN Corporation Information
    Table 147. DHN Description and Major Businesses
    Table 148. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 149. DHN Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. DHN Recent Developments
    Table 151. WINSUN Corporation Information
    Table 152. WINSUN Description and Major Businesses
    Table 153. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 154. WINSUN Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. WINSUN Recent Developments
    Table 156. Elanco Corporation Information
    Table 157. Elanco Description and Major Businesses
    Table 158. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 159. Elanco Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Elanco Recent Developments
    Table 161. Virbac Corporation Information
    Table 162. Virbac Description and Major Businesses
    Table 163. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 164. Virbac Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. Virbac Recent Developments
    Table 166. Jinyu Bio-Technology Corporation Information
    Table 167. Jinyu Bio-Technology Description and Major Businesses
    Table 168. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 169. Jinyu Bio-Technology Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 170. Jinyu Bio-Technology Recent Developments
    Table 171. ChengDu Tecbond Corporation Information
    Table 172. ChengDu Tecbond Description and Major Businesses
    Table 173. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 174. ChengDu Tecbond Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 175. ChengDu Tecbond Recent Developments
    Table 176. CAVAC Corporation Information
    Table 177. CAVAC Description and Major Businesses
    Table 178. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 179. CAVAC Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 180. CAVAC Recent Developments
    Table 181. Kyoto Biken Laboratories Corporation Information
    Table 182. Kyoto Biken Laboratories Description and Major Businesses
    Table 183. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 184. Kyoto Biken Laboratories Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 185. Kyoto Biken Laboratories Recent Developments
    Table 186. FATRO Corporation Information
    Table 187. FATRO Description and Major Businesses
    Table 188. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 189. FATRO Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 190. FATRO Recent Developments
    Table 191. Vaksindo Corporation Information
    Table 192. Vaksindo Description and Major Businesses
    Table 193. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 194. Vaksindo Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 195. Vaksindo Recent Developments
    Table 196. Bio-Labs Corporation Information
    Table 197. Bio-Labs Description and Major Businesses
    Table 198. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 199. Bio-Labs Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 200. Bio-Labs Recent Developments
    Table 201. Avimex Animal Health Corporation Information
    Table 202. Avimex Animal Health Description and Major Businesses
    Table 203. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 204. Avimex Animal Health Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 205. Avimex Animal Health Recent Developments
    Table 206. MEVAC Corporation Information
    Table 207. MEVAC Description and Major Businesses
    Table 208. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 209. MEVAC Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 210. MEVAC Recent Developments
    Table 211. Biovac Corporation Information
    Table 212. Biovac Description and Major Businesses
    Table 213. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 214. Biovac Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 215. Biovac Recent Developments
    Table 216. Atafen Corporation Information
    Table 217. Atafen Description and Major Businesses
    Table 218. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 219. Atafen Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 220. Atafen Recent Developments
    Table 221. Dyntec Corporation Information
    Table 222. Dyntec Description and Major Businesses
    Table 223. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 224. Dyntec Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 225. Dyntec Recent Developments
    Table 226. BioTestLab Corporation Information
    Table 227. BioTestLab Description and Major Businesses
    Table 228. BioTestLab Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 229. BioTestLab Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 230. BioTestLab Recent Developments
    Table 231. RVSRI Corporation Information
    Table 232. RVSRI Description and Major Businesses
    Table 233. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 234. RVSRI Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 235. RVSRI Recent Developments
    Table 236. Medion Corporation Information
    Table 237. Medion Description and Major Businesses
    Table 238. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 239. Medion Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 240. Medion Recent Developments
    Table 241. Key Raw Materials Lists
    Table 242. Raw Materials Key Suppliers Lists
    Table 243. Veterinary Vaccine Distributors List
    Table 244. Veterinary Vaccine Customers List
    Table 245. Veterinary Vaccine Market Trends
    Table 246. Veterinary Vaccine Market Drivers
    Table 247. Veterinary Vaccine Market Challenges
    Table 248. Veterinary Vaccine Market Restraints
    Table 249. Research Programs/Design for This Report
    Table 250. Key Data Information from Secondary Sources
    Table 251. Key Data Information from Primary Sources
List of Figures
    Figure 1. Veterinary Vaccine Product Picture
    Figure 3. Global Veterinary Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Live Attenuated Vaccines Product Picture
    Figure 4. Inactivated Vaccines Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Veterinary Vaccine Market Share by Application in 2021 & 2028
    Figure 7. Livestock
    Figure 8. Swine
    Figure 9. Chicken
    Figure 10. Dog & Cat
    Figure 11. Others
    Figure 12. Veterinary Vaccine Report Years Considered
    Figure 13. Global Veterinary Vaccine Sales 2017-2028 (M Doses)
    Figure 14. Global Veterinary Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Veterinary Vaccine Revenue 2017-2028 (US$ Million)
    Figure 16. Global Veterinary Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Veterinary Vaccine Sales Market Share by Region (2017-2022)
    Figure 18. Global Veterinary Vaccine Sales Market Share by Region (2023-2028)
    Figure 19. North America Veterinary Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 20. North America Veterinary Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Veterinary Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 22. Europe Veterinary Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Veterinary Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 24. Asia-Pacific Veterinary Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Veterinary Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 26. Latin America Veterinary Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Veterinary Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 28. Middle East & Africa Veterinary Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Veterinary Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Veterinary Vaccine in the World: Market Share by Veterinary Vaccine Revenue in 2021
    Figure 31. Global Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Veterinary Vaccine Sales Market Share by Type (2017-2028)
    Figure 33. Global Veterinary Vaccine Revenue Market Share by Type (2017-2028)
    Figure 34. Global Veterinary Vaccine Sales Market Share by Application (2017-2028)
    Figure 35. Global Veterinary Vaccine Revenue Market Share by Application (2017-2028)
    Figure 36. North America Veterinary Vaccine Sales Market Share by Type (2017-2028)
    Figure 37. North America Veterinary Vaccine Revenue Market Share by Type (2017-2028)
    Figure 38. North America Veterinary Vaccine Sales Market Share by Application (2017-2028)
    Figure 39. North America Veterinary Vaccine Revenue Market Share by Application (2017-2028)
    Figure 40. North America Veterinary Vaccine Sales Share by Country (2017-2028)
    Figure 41. North America Veterinary Vaccine Revenue Share by Country (2017-2028)
    Figure 42. U.S. Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Veterinary Vaccine Sales Market Share by Type (2017-2028)
    Figure 45. Europe Veterinary Vaccine Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Veterinary Vaccine Sales Market Share by Application (2017-2028)
    Figure 47. Europe Veterinary Vaccine Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Veterinary Vaccine Sales Share by Country (2017-2028)
    Figure 49. Europe Veterinary Vaccine Revenue Share by Country (2017-2028)
    Figure 50. Germany Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 51. France Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 55. Greece Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 56. Ukraine Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 57. Asia Pacific Veterinary Vaccine Sales Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Veterinary Vaccine Revenue Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Veterinary Vaccine Sales Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Veterinary Vaccine Revenue Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Veterinary Vaccine Sales Share by Region (2017-2028)
    Figure 62. Asia Pacific Veterinary Vaccine Revenue Share by Region (2017-2028)
    Figure 63. China Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 64. Japan Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 65. South Korea Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 66. India Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 67. Australia Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 68. Taiwan Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 69. Indonesia Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 70. Thailand Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 71. Malaysia Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 72. Philippines Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 73. Latin America Veterinary Vaccine Sales Market Share by Type (2017-2028)
    Figure 74. Latin America Veterinary Vaccine Revenue Market Share by Type (2017-2028)
    Figure 75. Latin America Veterinary Vaccine Sales Market Share by Application (2017-2028)
    Figure 76. Latin America Veterinary Vaccine Revenue Market Share by Application (2017-2028)
    Figure 77. Latin America Veterinary Vaccine Sales Share by Country (2017-2028)
    Figure 78. Latin America Veterinary Vaccine Revenue Share by Country (2017-2028)
    Figure 79. Mexico Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 80. Brazil Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 81. Argentina Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 82. Middle East and Africa Veterinary Vaccine Sales Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Veterinary Vaccine Revenue Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Veterinary Vaccine Sales Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Veterinary Vaccine Revenue Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Veterinary Vaccine Sales Share by Country (2017-2028)
    Figure 87. Middle East and Africa Veterinary Vaccine Revenue Share by Country (2017-2028)
    Figure 88. Turkey Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 89. Saudi Arabia Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 90. U.A.E Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 91. Egypt Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 92. South Africa Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 93. Israel Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 94. Kuwait Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 95. Iran Veterinary Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 96. Veterinary Vaccine Value Chain
    Figure 97. Veterinary Vaccine Production Process
    Figure 98. Channels of Distribution
    Figure 99. Distributors Profiles
    Figure 100. Bottom-up and Top-down Approaches for This Report
    Figure 101. Data Triangulation
    Figure 102. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture